We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age.
- Authors
Mook, S; Schmidt, M K; Weigelt, B; Kreike, B; Eekhout, I; van de Vijver, M J; Glas, A M; Floore, A; Rutgers, E J T; van 't Veer, L J
- Abstract
The majority of breast cancer patients are postmenopausal women who are increasingly being offered adjuvant chemotherapy. Since the beneficial effect of chemotherapy in postmenopausal patients predominantly occurs in the first 5 years after diagnosis, a prognostic marker for early events can be of use for adjuvant treatment decision making. The aim of this study was to evaluate the prognostic value of the 70-gene prognosis signature for early events in postmenopausal patients.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Vol 21, Issue 4, p717
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdp388